Notably, high ROCK2 expression levels were associated with poor prognoses in patients with iCCA, perihilar Cholangiocarcinoma (pCCA), and distal Cholangiocarcinoma (dCCA) (Fig. 1J–M). This evidence concerns the gene ROCK2 and infantile convulsions and choreoathetosis.